Gerald W. Mclaughlin - Net Worth and Insider Trading

Gerald W. Mclaughlin Net Worth

The estimated net worth of Gerald W. Mclaughlin is at least $28,175 dollars as of 2024-12-26. Gerald W. Mclaughlin is the CEO of Neos Therapeutics Inc and owns about 24,500 shares of Neos Therapeutics Inc (NEOS) stock worth over $28,175. Details can be seen in Gerald W. Mclaughlin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gerald W. Mclaughlin has not made any transactions after 2018-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gerald W. Mclaughlin

To

Gerald W. Mclaughlin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald W. Mclaughlin owns 4 companies in total, including Neos Therapeutics Inc (NEOS) , Skye Bioscience Inc (SKYE) , and Aytu BioPharma Inc (AYTU) among others .

Click here to see the complete history of Gerald W. Mclaughlin’s form 4 insider trades.

Insider Ownership Summary of Gerald W. Mclaughlin

Ticker Comapny Transaction Date Type of Owner
NEOS Neos Therapeutics Inc 2020-03-13 director & Chief Executive Officer
SKYE Skye Bioscience Inc 2014-10-31 director
AYTU Aytu BioPharma Inc 2021-03-19 director
LIMIT LIMIT 2022-10-01 director

Gerald W. Mclaughlin Latest Holdings Summary

Gerald W. Mclaughlin currently owns a total of 1 stock. Gerald W. Mclaughlin owns 24,500 shares of Neos Therapeutics Inc (NEOS) as of December 6, 2018, with a value of $28,175.

Latest Holdings of Gerald W. Mclaughlin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NEOS Neos Therapeutics Inc 2018-12-06 24,500 1.15 28,175

Holding Weightings of Gerald W. Mclaughlin


Gerald W. Mclaughlin Form 4 Trading Tracker

According to the SEC Form 4 filings, Gerald W. Mclaughlin has made a total of 0 transactions in Neos Therapeutics Inc (NEOS) over the past 5 years. The most-recent trade in Neos Therapeutics Inc is the acquisition of 17,097 shares on December 6, 2018, which cost Gerald W. Mclaughlin around $36,075.

Insider Trading History of Gerald W. Mclaughlin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gerald W. Mclaughlin Trading Performance

GuruFocus tracks the stock performance after each of Gerald W. Mclaughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald W. Mclaughlin is 5.58%. GuruFocus also compares Gerald W. Mclaughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald W. Mclaughlin within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gerald W. Mclaughlin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gerald W. Mclaughlin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Gerald W. Mclaughlin Ownership Network

Ownership Network List of Gerald W. Mclaughlin

No Data

Ownership Network Relation of Gerald W. Mclaughlin

Insider Network Chart

Gerald W. Mclaughlin Owned Company Details

What does Neos Therapeutics Inc do?

Who are the key executives at Neos Therapeutics Inc?

Gerald W. Mclaughlin is the director & Chief Executive Officer of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include Chief Financial Officer Richard I Eisenstadt , SVP & General Counsel John M Limongelli , and Chief Commercial Officer Thomas P Mcdonnell .

Neos Therapeutics Inc (NEOS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neos Therapeutics Inc Insider Transactions

No Available Data

Gerald W. Mclaughlin Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald W. Mclaughlin. You might contact Gerald W. Mclaughlin via mailing address: 227 Washington Street, Suite 200, Conshohocken Pa 19428.

Discussions on Gerald W. Mclaughlin

No discussions yet.